DCC and head and neck squamous cell carcinoma: These reports aligned with the results of the current study suggest that DCC is a tumor suppressor gene that is epigenetically inactivated by hypermethylation of its promoter region in most patients with HNSCC and that its methylation signal could be reversed by the action of drugs with epigenetic action, such as valproic acid.